- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Ph.D. Jay R. Luly
- Signature - Title
- /s/ Jay R. Luly, Ph.D. - Jay R. Luly, Ph.D.
- Location
- Watertown, MA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Ph.D. Jay R. Luly.
Follow Filing Activity
Follow Ph.D. Jay R. Luly and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Ph.D. Jay R. Luly
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals, Inc. | Common Stock, par value $0.01 per share | 7.7% | $9,659,503 | 1,703,616 | Jay R. Luly, Ph.D. | 12 Feb 2025 |
Schedules 13D/G Reported by Ph.D. Jay R. Luly:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.